유전자 증폭 기술 시장 분석과 예측 : 유형, 제품, 서비스, 기술, 용도, 최종 사용자, 프로세스, 구성 요소, 장치(-2034년)
Gene Amplification Technology Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Process, Component, Device
상품코드:1740672
리서치사:Global Insight Services LLC
발행일:2025년 06월
페이지 정보:영문 351 Pages
라이선스 & 가격 (부가세 별도)
한글목차
유전자 증폭 기술 시장은 2024년 189억 달러로 평가되었고, 2034년에는 423억 달러에 이르고, 약 8.4%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다. 바이오테크놀러지의 진보, 맞춤형 의료에 대한 수요가 높아지고, 정확한 유전자 분석의 필요성으로 주도되고 있습니다.
시장 개요 :
유전자 증폭 기술 시장은 장비, 시약, 서비스로 구분됩니다. 연구 및 감염증 검출 등 다양한 용도로 정확한 결과를 얻기 위해 필수적인 충실도의 높은 증폭을 실현하는데 중요한 역할을 하는 것에 기인하고 있습니다. 시약 제형의 기술 발전으로 성능이 더욱 향상되어 시장 리더십이 더욱 공고해졌습니다. 디지털 PCR이나 차세대 시퀀싱 등의 새로운 하위 부문은 보다 높은 분해능과 감도를 제공하는 능력에 의해 견인력을 늘리고 있어, 맞춤형 의료와 유전체학에 혁명을 가져오면 보다 큰 가능성을 제공합니다. 이 하위 부문은보다 종합적인 유전자 분석을 가능하게함으로써 시장에 영향을 미치고 기술 혁신을 촉진하고 다양한 분야에 걸친 유전자 증폭 기술의 범위를 확대하는 것으로 보입니다.
시장 세분화
유형
중합효소 연쇄반응(PCR), 등온 증폭, 리가제 연쇄반응(LCR)
제품
장비, 시약, 키트, 소프트웨어
서비스
맞춤형 증폭, 컨설팅, 교육, 유지 보수
기술
실시간 PCR, 디지털 PCR, 멀티플렉스 PCR
신청
임상 진단, 연구 개발, 법의 응용, 농업 생명 공학
최종 사용자
제약기업, 학술기관 및 연구기관, 병원 및 진단센터, 생명공학기업
프로세스
샘플 준비, 증폭, 검출
구성요소
열 순환기, 검출 시스템
장치
벤치탑 디바이스, 휴대용 디바이스
주요 동향과 촉진요인 :
유전자 증폭 기술 시장은 유전체학와 맞춤형 의료의 진보에 힘입어 강력한 성장을 이루고 있습니다. 보다 효율적이고 이용하기 쉬워지고 있습니다. 시장 개척이 진행되고 있으며, 바이오테크놀러지에 대한 투자의 확대와 연구개발 활동이 급증하고 있습니다. 디지털 PCR 및 차세대 시퀀싱의 혁신에 주력하는 기업들은 상당한 시장 점유율을 확보할 준비가 되어 있습니다.
주요 억제요인과 도전
유전자 증폭기술 시장에는 몇 가지 현저한 억제요인과 과제가 있습니다. 규제상의 장애물도 과제가 되고 있습니다. 지적재산의 문제는 더욱 상황을 복잡하게 하고 있어 특허분쟁이 기술 혁신이나 공동연구의 방해가 될 가능성이 있습니다. 이론적 우려가 계속 논의되고 있으며, 유전자 증폭 기술에 대한 사회의 인식과 수용에 영향을 미치고 있습니다.
목차
제1장 유전자 증폭 기술 시장 개요
조사 목적
유전자 증폭 기술 시장 정의와 조사 범위
보고서의 제한 사항
조사 대상 연도와 통화
조사 방법
제2장 주요 요약
제3장 시장에 관한 중요 인사이트
제4장 유전자 증폭 기술 시장 전망
유전자 증폭 기술 시장의 세분화
시장 역학
Porter's Five Forces 분석
PESTLE 분석
밸류체인 분석
4P 모델
ANSOFF 매트릭스
제5장 유전자 증폭 기술 시장 전략
상위 시장 분석
수급 분석
소비자의 구매 의욕
사례 연구 분석
가격 분석
규제 상황
공급망 분석
경쟁 제품 분석
최근 동향
제6장 유전자 증폭 기술 시장 규모
유전자 증폭 기술 시장 규모 : 금액별
유전자 증폭 기술 시장 규모, 수량별
제7장 유전자 증폭 기술 시장 : 유형별
시장 개요
중합효소 연쇄반응(PCR)
등온 증폭
리가제 연쇄반응(LCR)
기타
제8장 유전자 증폭 기술 시장 : 제품별
시장 개요
기기
시약
키트
소프트웨어
기타
제9장 유전자 증폭 기술 시장 : 서비스별
시장 개요
커스텀 증폭
컨설테이션
트레이닝
유지보수
기타
제10장 유전자 증폭 기술 시장 : 기술별
시장 개요
실시간 PCR
디지털 PCR
멀티플렉스 PCR
기타
제11장 유전자 증폭 기술 시장 : 용도별
시장 개요
임상 진단
연구개발
법의 응용
농업 생명공학
기타
제12장 유전자 증폭 기술 시장 : 최종 사용자별
시장 개요
제약기업
학술기관 및 연구기관
병원 및 진단센터
바이오테크놀러지 기업
기타
제13장 유전자 증폭 기술 시장 : 프로세스별
시장 개요
샘플 준비
증폭
검출
기타
제14장 유전자 증폭 기술 시장 : 구성 요소별
시장 개요
서멀 사이클러
검출 시스템
기타
제15장 유전자 증폭 기술 시장 : 장치별
시장 개요
벤치탑 장치
휴대용 장치
기타
제16장 유전자 증폭 기술 시장 : 지역별
개요
북미
미국
캐나다
유럽
영국
독일
프랑스
스페인
이탈리아
네덜란드
스웨덴
스위스
덴마크
핀란드
러시아
기타 유럽
아시아태평양
중국
인도
일본
한국
호주
싱가포르
인도네시아
대만
말레이시아
기타 아시아태평양
라틴아메리카
브라질
멕시코
아르헨티나
기타 라틴아메리카
중동 및 아프리카
사우디아라비아
아랍에미리트(UAE)
남아프리카
기타 중동 및 아프리카
제17장 경쟁 구도
개요
시장 점유율 분석
주요 기업의 포지셔닝
경쟁 리더십 매핑
벤더 벤치마킹
개발 전략의 벤치마킹
제18장 기업 프로파일
Bio-Rad Laboratories
QIAGEN
Takara Bio
LGC Biosearch Technologies
Fluidigm Corporation
Promega Corporation
BioMu00e9rieux
Analytik Jena
Meridian Bioscience
New England Biolabs
Eppendorf AG
Bioline
Roche Molecular Systems
Agrisera
GeneCopoeia
GenScript
Integrated DNA Technologies
Lucigen Corporation
PCR Biosystems
Zymo Research
SHW
영문 목차
영문목차
Gene Amplification Technology Market is anticipated to expand from $18.9 billion in 2024 to $42.3 billion by 2034, growing at a CAGR of approximately 8.4%. The market encompasses techniques and tools that enhance the replication of specific DNA sequences, crucial for diagnostics, research, and therapeutic applications. This market is driven by advancements in biotechnology, increasing demand for personalized medicine, and the need for precise genetic analysis. Key trends include innovations in polymerase chain reaction (PCR) technologies, digital PCR, and isothermal amplification methods, all contributing to enhanced accuracy and efficiency in genetic studies and medical diagnostics.
Market Overview:
The Gene Amplification Technology Market is segmented into instruments, reagents, and services. The reagents segment leads the market, driven by the increasing demand for precise and efficient amplification processes in research and clinical diagnostics. The dominance of reagents is attributed to their critical role in achieving high-fidelity amplification, essential for accurate results in various applications such as cancer research and infectious disease detection. Technological advancements in reagent formulations have further enhanced their performance, solidifying their market leadership. Emerging sub-segments, such as digital PCR and next-generation sequencing, are gaining traction due to their ability to provide higher resolution and sensitivity, offering significant potential to revolutionize personalized medicine and genomics. These sub-segments are poised to impact the market by enabling more comprehensive genetic analysis, thus driving innovation and expanding the scope of gene amplification technologies across diverse fields.
Clinical Diagnostics, Research and Development, Forensic Applications, Agricultural Biotechnology
End User
Pharmaceutical Companies, Academic and Research Institutes, Hospitals and Diagnostic Centers, Biotechnology Companies
Process
Sample Preparation, Amplification, Detection
Component
Thermal Cyclers, Detection Systems
Device
Benchtop Devices, Portable Devices
Geographical Overview:
The gene amplification technology market is witnessing varied growth across regions, each exhibiting unique characteristics. North America dominates, driven by advanced healthcare infrastructure and significant research investments. The presence of leading biotech firms further propels market expansion. Europe follows, supported by robust R&D activities and a strong focus on personalized medicine. Regulatory frameworks in the region also encourage innovation, boosting market growth. In Asia Pacific, the market is expanding rapidly. Increasing healthcare expenditure and growing awareness about genetic disorders fuel demand. Governments in the region are investing in biotechnology, fostering a conducive environment for market players. Latin America is emerging, with rising healthcare initiatives and improving infrastructure. The regionu2019s focus on biotechnology advancements enhances market prospects. The Middle East & Africa show promising potential, albeit at a nascent stage. Rising investments in healthcare and biotechnology drive market interest. Governments are recognizing the importance of modern healthcare solutions, which is expected to spur future growth. Each region presents distinct opportunities, making the global landscape of gene amplification technology diverse and dynamic.
Recent Developments:
The gene amplification technology market has experienced notable developments in recent months. Thermo Fisher Scientific announced a strategic partnership with a leading biotech firm to enhance its gene amplification capabilities, aiming to accelerate research and development in personalized medicine. Qiagen launched an innovative gene amplification kit that promises increased efficiency and accuracy, targeting researchers in genomics and molecular biology. In a significant merger, Bio-Rad Laboratories acquired a prominent gene amplification technology company to expand its product portfolio and strengthen its market position. Agilent Technologies unveiled a state-of-the-art gene amplification platform designed to improve throughput and reduce turnaround times, catering to the growing demand in clinical diagnostics. Additionally, regulatory changes in the European Union have introduced new guidelines for gene amplification technologies, emphasizing safety and efficacy, which are expected to influence market dynamics and drive innovation. These developments underscore the rapid evolution and strategic movements within the gene amplification technology sector.
Key Companies:
Bio- Rad Laboratories, QIAGEN, Takara Bio, LGC Biosearch Technologies, Fluidigm Corporation, Promega Corporation, Bio Merieux, Analytik Jena, Meridian Bioscience, New England Biolabs, Eppendorf AG, Bioline, Roche Molecular Systems, Agrisera, Gene Copoeia, Gen Script, Integrated DNA Technologies, Lucigen Corporation, PCR Biosystems, Zymo Research
Key Trends and Drivers:
The Gene Amplification Technology Market is experiencing robust growth, fueled by advancements in genomics and personalized medicine. The increasing prevalence of genetic disorders and the demand for precise diagnostics are driving the adoption of gene amplification technologies. Moreover, the integration of artificial intelligence in genomic research is streamlining data analysis, making it more efficient and accessible. Key trends include the rising application of gene amplification in oncology, where it aids in the early detection and treatment of cancer. The development of portable and cost-effective amplification devices is expanding the market reach to resource-limited settings. Additionally, the growing investment in biotechnology and the surge in research and development activities are propelling market expansion. Opportunities abound in the development of novel amplification techniques that offer higher accuracy and faster results. Companies focusing on innovations in digital PCR and next-generation sequencing are poised to capture significant market share. The emphasis on precision medicine and the increasing collaboration between academic institutions and industry players are expected to further drive market growth, positioning the gene amplification technology sector for sustained advancement.
Key Restraints and Challenges:
The Gene Amplification Technology Market is experiencing several notable restraints and challenges. One significant challenge is the high cost of gene amplification equipment, which restricts access for smaller research institutions and developing regions. Additionally, the complexity of gene amplification procedures requires skilled personnel, creating a barrier to entry for less experienced laboratories. Regulatory hurdles also pose a challenge, as stringent approval processes can delay the introduction of new technologies to the market. Intellectual property issues further complicate the landscape, with patent disputes potentially hindering innovation and collaboration. Finally, ethical concerns surrounding genetic manipulation continue to spark debate, impacting public perception and acceptance of gene amplification technologies. These factors collectively present substantial obstacles to the market's expansion and broader adoption.
Sources:
National Institutes of Health (NIH), World Health Organization (WHO), European Medicines Agency (EMA), U.S. Food and Drug Administration (FDA), National Center for Biotechnology Information (NCBI), European Molecular Biology Laboratory (EMBL), Human Genome Organisation (HUGO), American Society of Human Genetics (ASHG), European Society of Human Genetics (ESHG), International Society for Genetic and Genomic Medicine (ISGG), Genomics England, Wellcome Trust Sanger Institute, National Human Genome Research Institute (NHGRI), International Conference on Genomics, American Association for Cancer Research (AACR) Annual Meeting, Advances in Genome Biology and Technology (AGBT) Conference, European Society of Medical Oncology (ESMO) Congress, Cold Spring Harbor Laboratory Meetings, International Genomics Conference, Global Biotechnology Congress
Research Scope:
Estimates and forecasts the overall market size across type, application, and region.
Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.
Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.
TABLE OF CONTENTS
1: Gene Amplification Technology Market Overview
1.1 Objectives of the Study
1.2 Gene Amplification Technology Market Definition and Scope of the Report
1.3 Report Limitations
1.4 Years & Currency Considered in the Study
1.5 Research Methodologies
1.5.1 Secondary Research
1.5.2 Primary Research
1.5.3 Market Size Estimation: Top-Down Approach
1.5.4 Market Size Estimation: Bottom-Up Approach
1.5.5 Data Triangulation and Validation
2: Executive Summary
2.1 Summary
2.2 Key Opinion Leaders
2.3 Key Highlights of the Market, by Type
2.4 Key Highlights of the Market, by Product
2.5 Key Highlights of the Market, by Services
2.6 Key Highlights of the Market, by Technology
2.7 Key Highlights of the Market, by Application
2.8 Key Highlights of the Market, by End User
2.9 Key Highlights of the Market, by Process
2.10 Key Highlights of the Market, by Component
2.11 Key Highlights of the Market, by Device
2.12 Key Highlights of the Market, by North America
2.13 Key Highlights of the Market, by Europe
2.14 Key Highlights of the Market, by Asia-Pacific
2.15 Key Highlights of the Market, by Latin America
2.16 Key Highlights of the Market, by Middle East
2.17 Key Highlights of the Market, by Africa
3: Premium Insights on the Market
3.1 Market Attractiveness Analysis, by Region
3.2 Market Attractiveness Analysis, by Type
3.3 Market Attractiveness Analysis, by Product
3.4 Market Attractiveness Analysis, by Services
3.5 Market Attractiveness Analysis, by Technology
3.6 Market Attractiveness Analysis, by Application
3.7 Market Attractiveness Analysis, by End User
3.8 Market Attractiveness Analysis, by Process
3.9 Market Attractiveness Analysis, by Component
3.10 Market Attractiveness Analysis, by Device
3.11 Market Attractiveness Analysis, by North America
3.12 Market Attractiveness Analysis, by Europe
3.13 Market Attractiveness Analysis, by Asia-Pacific
3.14 Market Attractiveness Analysis, by Latin America
3.15 Market Attractiveness Analysis, by Middle East
